NCT06891248

Brief Summary

The objectives of this research are to determine the treatment effect size of OMM to wean patients off of the ventilator, determine the number of patients needed for a larger study (power), determine the willingness of patients/POAs to be recruited, identify the correct dosing of OMM and whether there are concerns for the safety of treatment, and determine whether the hypothesis is feasible for a larger study. The primary outcome measure is the duration of time until a subject is weaned off of mechanical ventilation using Osteopathic Manipulative Medicine (OMM). The secondary outcome measures (see the next section for further explanation) are to determine if OMM affects changes in morbidity and mortality, such as VBG/ABG, NIF, RSBI, P 0.1, FiO2, PEEP, mental status, hemodynamic stability (blood pressure), spontaneous TV, reintubation after extubation, and death.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

March 17, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 24, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 8, 2025

Completed
Last Updated

March 24, 2025

Status Verified

March 1, 2025

Enrollment Period

3 months

First QC Date

March 12, 2025

Last Update Submit

March 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time on ventilator

    Number of days that the patient is on the ventilator after inclusion in the study

    90 days

Secondary Outcomes (11)

  • Ventilator associated measurement

    90 days

  • Ventilator associated measurement

    90 days

  • Ventilator associated measurement

    90 days

  • Ventilator associated measurement

    90 days

  • Ventilator associated measurement

    90 days

  • +6 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Subjects in these arms only receive conventional care

Osteopathic Manipulative Treatment

EXPERIMENTAL

The standard OMM treatment arm includes a 10-minute treatment time for 5 body regions with up to 3 providers working on the patient simultaneously. The OMM attending physician will be physically present and supervising the treatment, and may be participating in the treatment. The 5 body regions include Head, Neck, Thoracic, Ribs, and Abdominal/Diaphragm. The standard technique for the OMM arm includes OA decompression, screening and treating any cervical dysfunction, thoracic inlet myofascial release, rib raising, thoracic paraspinal inhibition, and abdominal diaphragm myofascial release. There is an opportunity for an additional 5 minutes of treatment time and additional regions if the lead physician determines it is appropriate based on clinical judgment. The additional 4 regions include Upper Extremity, Lower Extremity, Lumbar, Pelvis, and Sacrum.

Procedure: Osteopathic Manipulative Treatment

Interventions

See treatment arm

Osteopathic Manipulative Treatment

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute respiratory failure (hypoxic, hypercapnic, or neuromuscular)
  • Not making satisfactory progress with weaning after being on the ventilator for more than 48 hours
  • Clinical stability for pressure support trial with ventilator to monitor ventilation progression
  • Pulmonology must be following the patient for standardized ventilator management approach and interventions as needed
  • Medical power of attorney (POA) or legally authorized representative (LAR) who is able to consent subject for trial enrollment and treatment
  • Patients who were not referred to the OMM service

You may not qualify if:

  • Age less than 18 years old or more than 85 years old
  • BMI\>60
  • Moderate/severe neurological disease with expectation of non-progression off the ventilator or poor quality of life predicted (including end-stage dementia with the expectation of non-progression off ventilator, multiple sclerosis, ALS, anoxic brain injury, etc)
  • Status epilepticus or EEG result pending
  • Post-arrest hypothermia protocol
  • Acute stroke
  • Acute rib fractures preventing the implementation of the treatment protocol
  • Acute spinal injury preventing the implementation of the treatment protocol
  • Recent head injury requiring close clinical monitoring
  • Ejection Fraction less than 15%
  • Pleural effusion requiring procedural intervention or inhibiting ventilator progress
  • Pericardial effusion or tamponade requiring procedural intervention or inhibiting ventilator progress
  • ACLS/cardiac arrest within the past 72 hours
  • Confirmed opioid overdose with positive urine drug screen and response to naloxone
  • Patients who were referred to the OMM service

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Respiratory Insufficiency

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Amber Hood, DFS

    OSU CHS

    STUDY DIRECTOR

Central Study Contacts

Cameron Henderson, DO

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 24, 2025

Study Start

March 17, 2025

Primary Completion

June 8, 2025

Study Completion

June 8, 2025

Last Updated

March 24, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share